Psychedelic Therapy—A New Paradigm of Care for Mental Health
JAMA, ISSN: 1538-3598, Vol: 330, Issue: 9, Page: 813-814
2023
- 14Citations
- 36Captures
- 31Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes13
- 13
- Policy Citations1
- Policy Citation1
- Captures36
- Readers36
- 36
- Mentions31
- News Mentions30
- News30
- Blog Mentions1
- Blog1
Most Recent Blog
Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next
Psychedelics made their mark this year—not as counterculture party drugs, but as a new paradigm in mental health therapy. In June, Australia became the first country to greenlight MDMA, popularly known as molly or ecstasy, and psilocybin, the active ingredient in magic mushrooms, to treat post-traumatic stress disorder (PTSD) and depression. MDMA also inched closer to approval in the US for PTSD,
Most Recent News
HMN 2025: Travel beyond time
Do you know Travel beyond time | Psychology today Time is the fundamental aspect of human experience, but in particular, our perception can be greatly
Article Description
JAMA
Bibliographic Details
American Medical Association (AMA)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know